Dec 19, 2018
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.30 to $4.50.
The split itself did not change the total investment value.
Medexus Pharmaceuticals Inc. (TSX:MDP) operates in the Pharmaceuticals: major industry.
Medexus Pharmaceuticals Inc. company overviewMedexus Pharmaceuticals Inc.'s most recent stock split was on December 19, 2018. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
Medexus Pharmaceuticals Inc. (TSX:MDP) has split its stock 2 times: a 1-for-3 reverse split on December 27, 2013 and a 1-for-15 reverse split on December 19, 2018.
Medexus Pharmaceuticals Inc. has split its stock 2 times. This history records 2 reverse splits between December 27, 2013 and December 19, 2018.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Medexus Pharmaceuticals Inc.'s 1-for-15 reverse split on December 19, 2018, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Medexus Pharmaceuticals Inc. has not announced a new split in our records. Its most recent split was on December 19, 2018, 7 years ago. Companies announce splits in advance, and any new TSX:MDP split will appear on this page.
Already premium?